Find jobs, apply now.
Browse live opportunities
Toggle between list and map views, adjust filters, and surface the most relevant matches for your team.
Toggle between list and map views, adjust filters, and surface the most relevant matches for your team.
World Wide relies on analytics signals to operate securely and keep research services available. Accept to continue, or leave the site.
Review the Privacy Policy for details about analytics processing.
Connect with opportunities and talent
Looking for a supportive, dynamic and inclusive environment to do cutting edge science? The Panagiotakos Lab at Mount Sinai has two postdoctoral positions open! Links for both positions below – come join us if you love neural development, ion channels or anything in between! The Panagiotakos Lab, in the Departments of Psychiatry and Neuroscience at the Icahn School of Medicine at Mount Sinai in New York, is seeking postdoctoral fellows (recently completed Ph.D., M.D. or M.D./Ph.D.) with expertise in calcium imaging, electrophysiology, developmental neuroscience, stem cell biology, and/or genomics/sequencing approaches to study cellular and molecular mechanisms that underlie the acquisition of cell fate during mammalian brain development. Dr. Panagiotakos’ team combines multiple complementary approaches, including genetic mouse models, calcium imaging, fluorescence microscopy, pharmacology, cortical slice cultures, and various omics and biochemical analyses, to interrogate roles for calcium signaling, electrical activity, ion channel splice isoforms, and disease risk genes during normal development and in the context of neuropsychiatric disorders of developmental origin. The qualified candidates will use cutting-edge cellular/molecular biology, imaging and sequencing approaches in these studies, including long-isoform sequencing, CUT&RUN, and live imaging, to investigate the impact and mechanistic underpinnings of disease-relevant ion channels and calcium signaling on cellular events during brain development, including proliferation, migration, neurogenesis and gliogenesis.
We are seeking for highly motivated postdoctoral neuroscientists with a strong background in neuroscience to study the functional development of sensory circuits and spontaneous activity programs in mice using in vivo meso-scale and two-photon calcium imaging, and in vivo electrophysiology.
The laboratory of Silvia De Rubeis, PhD, at the Seaver Autism Center for Research and Treatment in the Department of Psychiatry at the Icahn School of Medicine at Mount Sinai in New York, is seeking an ambitious, creative, and motivated postdoctoral fellow with expertise in neuroscience to study the mechanisms underlying intellectual disability (ID) and autism spectrum disorder (ASD). Dr. De Rubeis’ laboratory aims at translating emerging genetic findings from large-scale genomic studies into functional analyses in cellular and mouse models with the goal of understanding the pathogenic underpinnings of ID and ASD. The laboratory focuses on DDX3X syndrome, a rare genetic disorder associated with ID and ASD, using cellular and animal models. Our team currently includes two postdoctoral fellows, a PhD student, three research associates, one undergraduate student, and three high-school students.
The Quattrocolo group at the Kavli Institute for Systems Neuroscience has an opening for a postdoctoral candidate in cell and molecular neurobiology. The main research interest of the lab is the study of cortical circuit development. In particular we focus on understanding the influence of specific cell types (such as Cajal-Retzius cells) in the establishment and maturation of the circuit of the hippocampal-entorhinal area. We aim to combine different techniques, from anatomical tracing to transcriptomic, from in vitro to in vivo physiology to reach our goal. The successful candidate will be expected to perform analysis of protein and gene expression levels in physiological and non-physiological development. The position is a full time (100%) position, with a 2-4 years contract, starting in early 2021.